From real estate to healthcare and everything in between, it seems that Highland Capital has a hand in all of the world’s most well-capitalized industries. Chief among its publicly traded offerings is the Highland “Long-Short Healthcare Fund”, and this particular fund is run by Managing Director Nate Burns and Highland President James Dondero.

The “Long-Short Healthcare Fund” is currently invested in several classes of stock across the marketplace. This is an equity-only fund, and capital is not invested in debt offerings of any kind.

In summary, the “Long-Short Healthcare Fund” is currently invested in the following equity securities across all of its portfolio companies:

Class A Stock – These shares come with more voting rights than other equity securities, allowing Dondero and Burns to hold sway over the operational decisions of corporations inside of their portfolio.

Class C Stock – It is not uncommon for one mutual fund to invest another mutual fund’s Class C shares, and this is exactly the strategy that Dondero and Burns have decided to employ.

Class Z Stock – Class Z shares are also a class of mutual fund equities, the Class Z Shares offered by Highland Capital Management’s Long-Short Healthcare Fund have gained more than 5% over the last decade.

Index Funds – Currently, the portfolio has more than 20% of its capital allocated to shares of the Standard & Poor’s 500 (S&P 500), a selection of America’s largest corporations.

Although the healthcare field has opportunities in several different verticals, Highland has decided to narrow its investment focus to biotechnology companies that show promise in developing nascent therapeutics and associated technologies. Go Here to learn more.

The current portfolio includes substantial stakes in Minerva Neurosciences Inc., Biohaven Pharmaceutical, and Ascendis Pharma. View More Information Here.

Gilson Finkelsztain, the former Member of the Executive Board at BM&FBovespa, hoped Brazil’s number of investors would reach the 5 million range. That hasn’t happened yet. However, the nation did hit an impressive milestone. 1 million people have money in the market through the Brazil Exchange.

The figure could increase in time. Empiricus Publishing could benefit if the number were to rise. Empiricus involves itself in the publishing of investment newsletters. At present, the company has 350,000 paid subscribers. These subscribers can read articles on stocks and other assets crafted by established analysts.

A significant number of investors in the market have an interest in learning about stocks. The one-million investor figure gives the management at Empiricus and idea about how many potential subscribers the company could sign. Refer to This Article to learn more.

Since the newsletter feature articles on making money written by experts, why wouldn’t an investor want to read the content? As with any other product or service, marketing and promotions play a role in how Empiricus could connect with potential subscribers. The classic concept of offering special discounts was one way the company tried to connect with new subscribers. The discount deals rolled out during Consumer Week, which seems to be good timing. Go Here for more information.

The readers of the newsletters absorb the information in different ways. A decent percentage of readers, however, did choose to work with brokers. Their money found its way to investment vehicles far more dynamic than low-interest savings accounts. Per a research study, Empiricus Research discovered a shift in reader behaviors. The number of readers with money in the market shifted from 35% to 60%.

Empiricus also intends to explore more dynamic strategies. The company purchased 50% of O Antagonista website. The other half of the website falls under the ownership of Diogo Mainardi and Mario Sabino. At present, Empiricus intends to work hard at increasing its overall annual revenue.

Readers interested in varieties of topics should appreciate what Empiricus Publishing offers. The company puts out 24 newsletters that focus on all manner of different topics. Whether you wish to read about mutual funds, equities, or real estate-based funds, Empiricus publishes such content and more. And the more someone reads about multiple topics, the more knowledgeable he or she may become.

Investors do seek knowledge and information. Empiricus intends to provide something of value to these persons. At present, 350,000 people subscribe to the company’s publication. Such a vast readership reflects a significant percentage of investors in Brazil.

Contributing to the content are 30 analysts from well-respected entities. Through working with established analysts, material presents on the various newsletters’ digital pages may prove impressive.

Published content isn’t the only thing Empiricus promotes. Readers can also look forward to company-sponsored events featuring top speakers such as Alan Greenspan and Daniel Kahneman among others. Hearing a learned person speak at a live event can leave a valuable impression. Read This Article to learn more.

The history of Empiricus shows consistent growth. Interestingly, the company is relatively new. Felipe Miranda and Rodolfo Amstalden founded the company in 2009. In 2012, Empiricus dedicated a great deal of its business strategy to focusing on individuals. In 2013, the company formed a partnership with Agora, an American business entity. Things seemed to work out well. In addition to the large paying subscriber base, Empiricus provides free content to roughly 2 million readers.

Several philosophical approaches guide the publishing house. One idea stresses the importance of data and tests. Opinions matter less because they are, after all, merely rhetoric. Provable tests and fact-based data count for more. A closer look at the overall philosophies of the company may be worthwhile to anyone interested in discovering more about the company’s publishing and editorial theories. Get Additional Information Here.